학술논문
Second-line treatments after FOLFIRINOX or gemcitabine plus nab-paclitaxel failure for unresectable pancreatic cancer under real-life clinical conditions: Experience at a single institute
Document Type
Abstract
Source
In Pancreatology August 2016 16(4) Supplement:S172-S173
Subject
Language
ISSN
1424-3903